Tyvin Rich is Chief Medical Officer at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). They have made 1 open-market trade across 1 company since 2022, most recently 2022-12-29.
CIK 0001945208
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SHPH | 2,429 | $13K |
Shares reported on the most recent Form 4, priced at the 2023-01-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SHPH | SELL | 2022-12-29 | 2023-01-03 | $1.61 | $2K | -5.9% | +17.4% | +17.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.